Pancreatic Cancer Research

ResearcherAntiCancer (United States)No recent work listed

Lei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2227-0613; OpenAlex author ID A5100780609. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122. First author DOI 10.1186/s12957-021-02232-3↗
  2. Identification of miR-601 as a novel regulator in the development of pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2016.12.090↗
  3. Efficacy comparison of traditional Chinese medicine LQ versus gemcitabine in a mouse model of pancreatic cancer. Co-author DOI 10.1002/jcb.24561↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junhong Ma · 1 shared paper, 2021 · strength 0.19
  2. Xibao Hu · 1 shared paper, 2021 · strength 0.19
  3. Wenxi Cao · 1 shared paper, 2017 · strength 0.09
  4. Haixin Qian · 1 shared paper, 2017 · strength 0.09
  5. Michael Bouvet · 1 shared paper, 2013 · strength 0.04
  6. Robert M. Hoffman · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.